Table 3: ALT levels of the pregnant women during pregnancy and postpartum.

Group A
(n=264)
Group B
(n=136)
Group C
(n=251)
P
Group B vs. C

Baseline (U/L)33.13±9.95127.49±68.23120.63±67.070.340
 0-40218 (82.6%)000.369
 41-8046 (17.4%)42 (30.9%)90 (35.9%)
 81-200073 (53.68%)134 (53.39%)
 201-400021 (15.44%)26 (10.36%)
 401-001 (0.40%)
Before delivery (U/L)32.89±9.2553.13±14.8842.00±12.01<0.001
 0-40219 (83.0%)31 (22.8%)134 (53.4%)<0.001
 41-8045 (17.0%)97 (71.3%)114 (45.4%)
 81-20008 (5.9%)3 (1.2%)
 201-400000
 401-000
7 months postpartum (U/L)27.24±8.2160.18±14.1231.06±1.66<0.001
 0-40241 (91.3%)3 (2.2%)210 (83.7%)<0.001
 41-8023 (8.7%)116 (85.3%)41 (16.3%)
 81-200017(12.5%)0
 201-400000
 401-000
1 year postpartum (U/L)26.54±7.8558.83±1.1629.01±8.66<0.001
 0-40243 (92.0%)4 (2.9%)219 (87.3%)<0.001
 41-8021 (8.0%)119 (87.5%)32 (12.7%)
 81-200013(9.6%)0
 201-400000
 401-000

Values are reported as mean ± standard deviation, compared with t test; or number (percentage), compared with chi-square test or fisher's test, unless otherwise indicated. n, number of patients; ALT, alanine aminotransferase.